To establish that human CD20+ T cells solely are a product of trogocytosis, we next measured co-expression of CD20 on T cells with the B-cell markers CD21, CD22, and CD180 in the blood of healthy donors and CSF of patients shortly after experiencing their first attack in multiple sclerosis as a representative of an inflamed environment. The gene discussed is CD22; the disease is multiple sclerosis.